EP3753938
SUBSTUTUTED IMIDAZO-QUINOLINES AS NLRP3 MODULATORS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
16.2.2018EP published:
20.3.2024EP application number:
20169634.1
EPO information:
European Patent Register
Max expiry date:
15.2.2038
Title in English:
SUBSTUTUTED IMIDAZO-QUINOLINES AS NLRP3 MODULATORSLanguage of the patent:
English
Timeline
Today
16.2.2018EP application
20.3.2024EP Publication
Owner
Name:
Innate Tumor Immunity, Inc.Address:
Route 206 and Province Line Road, Princeton, New Jersey 08543, US
Inventor
Name:
GLICK, GaryAddress:
Ann Arbor, MI 48103, US
Name:
GHOSH, ShomirAddress:
Brookine, MA 02446, US
Name:
ROUSH, William R.Address:
Tequesta, FL 33469, US
Name:
OLHAVA, Edward JamesAddress:
Newton, MA 02460, US
Name:
O'MALLEY, DanielAddress:
Princeton, NJ 08543, US
Priority
Number:
201762460677 PDate:
17.2.2017Country:
US
Number:
201762490881 PDate:
27.4.2017Country:
US
Number:
201762573991 PDate:
18.10.2017Country:
US
Classification
Categories:
C07D 471/04, A61P 35/00, A61P 37/00, A61K 31/437